Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Participants needed: 150
Trial details
Phase: Phase 3Age: 40+Biological sex: AllType: InterventionalSponsor: Saol Therapeutics IncUpdated: Jun 23, 2026Locations: 21
Eligibility criteria

Male or female patients ≥ 40 years of age [+7]

Non-OA inflammatory arthritis [+13]

Status: Available

Expanded Access Treatment Protocol With DCA for Patients With PDCD

Expanded Access (EA) will provide a transition to continue therapy for those patients who are currently in the open label extension of the Phase III study, SL 1009-01, while also allowing new patients diagnosed with PDCD who meet the eligibility criteria to also have access to therapy that would be otherwise unavailable.

Trial details
Age: 0-17Biological sex: AllType: Expanded AccessSponsor: Saol Therapeutics IncUpdated: May 8, 2025
Eligibility criteria

Ages 0 through adulthood [+3]

A genetic mitochondrial disease other than those stipulated under inclusion crit... [+8]